Molecular target characterization and antimyeloma activity of the novel, insulin-like growth factor 1 receptor inhibitor, GTx-134.
about
The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potentialDiscovery and preclinical characterization of novel small molecule TRK and ROS1 tyrosine kinase inhibitors for the treatment of cancer and inflammation.Kinase inhibitors as potential agents in the treatment of multiple myeloma.
P2860
Molecular target characterization and antimyeloma activity of the novel, insulin-like growth factor 1 receptor inhibitor, GTx-134.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Molecular target characterizat ...... 1 receptor inhibitor, GTx-134.
@en
Molecular target characterizat ...... 1 receptor inhibitor, GTx-134.
@nl
type
label
Molecular target characterizat ...... 1 receptor inhibitor, GTx-134.
@en
Molecular target characterizat ...... 1 receptor inhibitor, GTx-134.
@nl
prefLabel
Molecular target characterizat ...... 1 receptor inhibitor, GTx-134.
@en
Molecular target characterizat ...... 1 receptor inhibitor, GTx-134.
@nl
P2093
P50
P1476
Molecular target characterizat ...... 1 receptor inhibitor, GTx-134
@en
P2093
Christopher C Coss
Chungyee Leung-Hagesteijn
Ivan George Fantus
Jessica Zive
Sheng-Ben Liang
Xiu-Zhi Yang
Young Trieu
P304
P356
10.1158/1078-0432.CCR-10-3097
P407
P577
2011-06-01T00:00:00Z